Bill Ackman: Venezuela Could Kill Herbalife's Earnings

Oct. 13 (Bloomberg) -- Bill Ackman, chief executive officer at Pershing Square Holdings Ltd., discusses the latest developments in the joint pursuit of Allergan with Valeant Pharmaceuticals and how Herbalife results may suffer from the currency exchange rate in Venezuela. He speaks in an exclusive interview with Bloomberg’s Hans Nichols.

Full Show: What'd You Miss? (08/22)
15:16 - Guests include: Miller Tabak's Matt Maley and Temple University's Alexandra Guisinger. (Source: Bloomberg)
  • Full Show: Bloomberg Technology (08/22)
  • SAP's Russell Sees Strong Growth in India, Japan
  • The Key Takeaways From Salesforce's Earnings